— Illustrative image from U.S. Patent No. 6,280,198
Today we are featuring a 2001 patent originally assigned to Scientific Learning Corp, and now to Lumos Labs Inc. (As mentioned, we are featuring a foundational Pervasive Neurotech patent a day, from older to newer by issue date)
U.S. Patent No. 6,280,198: Remote computer implemented methods for cognitive testing
- Assignee(s): Scientific Learning Corp; Lumos Labs Inc.
- Inventor(s): Barbara Calhoun, Bret E. Peterson, Michael M. Merzenich
- Technology Category: NeuroCognitive Training
- Issue Date: August 28, 2001
The ‘198 patent describes techniques for improving the frequency and regularity at which an individual can take cognitive tests. Read the rest of this entry »
“The future is already here – it’s just not evenly distributed” — writer and futurist William Gibson
If you work at, compete with, or learn from, any of the companies below, you may want to know what they are up to and why, via SharpBrains’ objective and independent market reports. Which are available at discounted price until the end of tomorrow Thursday, March 31st.
1) Neurotech report & Infographic: Pervasive Neurotechnology: A Groundbreaking Analysis of 10,000+ Patent Filings Transforming Medicine, Health, Entertainment and Business
Leading non-invasive neurotech patent holders (*Detailed IP portfolio profile included within report): Read the rest of this entry »
Lumosity’s Stumble Reveals How We Think About Thinking (BuzzFeed News):
“The ads were pervasive, popping up on CNN, Fox News, NPR, and Google searches. And they were persuasive: Playing Lumosity games would do your brain good…But these claims sounded a little too rosy to the Federal Trade Commission, which Read the rest of this entry »
Videogame Maker Seeks to Treat ADHD (The Wall Street Journal):
“Doctors don’t usually prescribe videogame play. But one company, which has just raised $30.5 million from venture-capital investors, hopes to change that.
Boston-based Akili Interactive Labs Inc. is developing a videogame it believes could replace pills as a treatment for attention-deficit hyperactivity disorder. Read the rest of this entry »
Lumosity must pay $2 million after “unfounded” brain game claims (Fast Company):
“The maker of brain game app Lumosity has agreed to pay $2 million to settle charges brought by the Federal Trade Commission, which alleged it deceived consumers about the product’s brain-training benefits.
The FTC said Tuesday that Lumosity made “unfounded claims” that its games could help users do better at work and school and help reduce the effects of conditions including Read the rest of this entry »